Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Fresenius Medical Care AG & Co. KGaA's quarterly P/E stands at 10.4x, down 88.9% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 81.4% YoY to 6.0x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 11.84 | 10.45 | 14.01 | 18.31 | 23.94 | 94.33 | 28.03 | 29.83 | 80.33 | 23.67 | 56.68 | 37.39 | 53.15 |
| — | -88.9% | -50.0% | -38.6% | -70.2% | +298.5% | -50.6% | -20.2% | +51.1% | -30.5% | +223.0% | -22.0% | -11.6% | |
| P/S Ratio | 0.59 | 0.67 | 0.79 | 0.87 | 0.75 | 1.31 | 1.31 | 1.18 | 1.20 | 0.92 | 0.96 | 1.09 | 0.99 |
| — | -48.6% | -40.0% | -25.6% | -37.5% | +42.2% | +36.8% | +7.7% | +20.4% | -4.2% | +18.9% | -29.0% | -54.2% | |
| P/B Ratio | 0.81 | 0.95 | 1.11 | 1.17 | 0.94 | 1.69 | 1.69 | 1.48 | 1.50 | 1.24 | 1.23 | 1.41 | 1.23 |
| — | -43.4% | -34.5% | -20.7% | -37.0% | +36.3% | +37.6% | +4.6% | +21.7% | -0.3% | +24.8% | -25.5% | -54.8% | |
| P/FCF | — | — | 7.01 | 6.75 | 214.08 | 11.24 | 7.63 | 19.79 | — | 9.77 | 7.61 | 6.18 | 6643.04 |
| — | — | -8.2% | -65.9% | — | +15.0% | +0.3% | +220.2% | — | -24.4% | -8.1% | -51.0% | — | |
| EV / EBITDA | 6.33 | 6.03 | 7.06 | 8.14 | 8.40 | 32.38 | 10.51 | 10.19 | 11.05 | 8.49 | 9.76 | 10.35 | 11.00 |
| — | -81.4% | -32.8% | -20.1% | -24.0% | +281.2% | +7.7% | -1.6% | +0.5% | -7.5% | +30.5% | -24.6% | -34.7% | |
| EV / EBIT | 11.34 | 10.33 | 12.91 | 14.58 | 17.60 | 32.38 | 18.15 | 18.68 | 32.04 | 15.95 | 21.76 | 21.50 | 28.16 |
| — | -68.1% | -28.9% | -21.9% | -45.1% | +103.0% | -16.6% | -13.1% | +13.8% | -22.7% | +45.7% | -27.5% | -21.1% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Fresenius Medical Care AG & Co. KGaA's operating margin was 11.7% in Q4 2025, up 2.0 pp QoQ and up 6.6 pp YoY. This marks the 5th consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 9.3% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin expanded 9.6% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.6% | 27.4% | 25.4% | 25.3% | 24.3% | 25.0% | 24.1% | 24.5% | 24.8% | 27.1% | 24.9% | 24.8% | 24.4% |
| — | +9.6% | +5.6% | +3.6% | -2.4% | -7.7% | -3.3% | -1.4% | +1.7% | +0.3% | +2.0% | -5.3% | -5.4% | |
| Operating Margin | 9.3% | 11.7% | 9.8% | 8.9% | 6.8% | 5.1% | 9.7% | 8.9% | 5.2% | 8.6% | 6.6% | 7.4% | 5.5% |
| — | +129.7% | +0.3% | -0.5% | +30.4% | -40.5% | +48.2% | +20.5% | -6.2% | +21.7% | -29.1% | +3.4% | -27.4% | |
| Net Margin | 5.0% | 6.4% | 5.6% | 4.7% | 3.1% | 1.3% | 4.5% | 3.9% | 1.5% | 3.8% | 1.7% | 2.9% | 1.8% |
| — | +390.1% | +25.7% | +19.8% | +106.3% | -65.1% | +162.9% | +35.2% | -17.8% | +35.6% | -62.3% | -6.2% | -47.2% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 6.5% | 2.3% | 1.9% | 1.5% | 1.0% | 0.4% | 1.4% | 1.2% | 0.5% | 1.2% | 0.6% | 0.9% | 0.6% |
| — | +429.8% | +37.0% | +22.4% | +104.2% | -64.7% | +156.8% | +32.8% | -15.5% | +44.0% | -61.3% | -5.4% | -49.2% | |
| ROA | 3.0% | 1.1% | 0.9% | 0.7% | 0.5% | 0.2% | 0.6% | 0.5% | 0.2% | 0.5% | 0.2% | 0.4% | 0.2% |
| — | +421.8% | +37.8% | +28.4% | +119.4% | -62.5% | +169.5% | +37.9% | -13.9% | +44.3% | -61.5% | -4.4% | -47.0% | |
| ROIC | 5.6% | 1.9% | 1.5% | 1.3% | 1.0% | 0.8% | 1.4% | 1.2% | 0.7% | 1.2% | 0.9% | 1.0% | 0.7% |
| — | +146.8% | +11.2% | +6.2% | +36.5% | -36.8% | +51.3% | +23.6% | -0.0% | +31.8% | -26.2% | +6.6% | -27.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Fresenius Medical Care AG & Co. KGaA's Debt/EBITDA ratio is 11.4x, down from 12.0x last quarter — elevated, raising questions about debt serviceability. The current ratio has weakened 9.6% YoY to 1.26x, tightening the short-term liquidity position.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.76 | 0.75 | 0.77 | 0.70 | 0.70 | 0.76 | 0.78 | 0.80 | 0.81 | 0.84 | 0.88 | 0.87 |
| — | +8.3% | -0.8% | -0.8% | -12.2% | -14.3% | -9.7% | -11.4% | -8.5% | -4.8% | +2.0% | -1.0% | -5.1% | |
| Debt / EBITDA | 3.30 | 11.41 | 12.02 | 13.77 | 14.94 | 39.17 | 13.54 | 14.51 | 15.90 | 14.15 | 16.68 | 16.52 | 18.98 |
| — | -70.9% | -11.2% | -5.1% | -6.0% | +176.8% | -18.8% | -12.2% | -16.3% | -9.3% | +17.8% | -7.8% | +9.1% | |
| Current Ratio | 1.26 | 1.26 | 1.36 | 1.44 | 1.46 | 1.40 | 1.37 | 1.46 | 1.50 | 1.42 | 1.37 | 1.26 | 1.32 |
| — | -9.6% | -1.1% | -1.8% | -2.4% | -1.7% | +0.4% | +16.2% | +13.5% | +12.2% | +2.2% | +6.9% | +4.6% | |
| Quick Ratio | 0.92 | 0.92 | 1.00 | 1.08 | 1.08 | 1.03 | 1.02 | 1.09 | 1.14 | 1.07 | 1.02 | 0.91 | 0.96 |
| — | -10.9% | -2.1% | -0.4% | -5.2% | -3.1% | -0.2% | +20.0% | +18.6% | +16.8% | +6.2% | +7.1% | +3.8% | |
| Interest Coverage | — | — | 6.44 | 4.40 | 3.46 | 2.57 | 4.68 | 4.13 | 2.37 | 3.84 | 2.84 | 3.40 | 2.75 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonFresenius Medical Care AG & Co. KGaA's current P/E is 11.8x. The average P/E over the last 4 quarters is 16.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Fresenius Medical Care AG & Co. KGaA's current operating margin is 9.3%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Fresenius Medical Care AG & Co. KGaA's business trajectory between earnings reports.